Edwin A. Rosado-Olivieri

Edwin A. Rosado-Olivieri

Auto-generated profile, based on publicly available information

Edwin A. Rosado-Olivieri

Laboratory of Synthetic Embryology, The Rockefeller University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
EREdwin A. Rosado-Olivieri
Edwin A. Rosado-Olivieri
KAKendall Anderson
Kendall Anderson
JKJennifer H. Kenty
Jennifer H. Kenty
DMDouglas A. Melton
Douglas A. Melton
Stem cell-derived insulin-producing beta cells (SC-β) offer an inexhaustible supply of functional β cells for cell replacement therapies and disease modeling for diabetes. While successful directed differentiation protocols for this cell type have been described, the mechanisms controlling its differentiation and function are not fully understood. Here we report that the Hippo pathway controls the proliferation and specification of pancreatic progenitors into the endocrine lineage. Downregulation of YAP, an effector of the pathway, enhances endocrine progenitor differentiation and the generation of SC-β cells with improved insulin secretion. A chemical inhibitor of YAP acts as an inducer of endocrine differentiation and reduces the presence of proliferative progenitor cells. Conversely, sustained activation of YAP results in impaired differentiation, blunted glucose-stimulated insulin secretion, and increased proliferation of SC-β cells. Together these results support a role for YAP in controlling the self-renewal and differentiation balance of pancreatic progenitors and limiting endocrine differentiation in vitro.

5 September 2023 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
RJRobert Jordan
Robert Jordan
SFStephanie L Ford-Scheimer
Stephanie L Ford-Scheimer
RARodolfo M Alarcon
Rodolfo M Alarcon
Anthony AtalaAnthony Atala
Anthony Atala
Jeffrey T BorensteinJeffrey T Borenstein
Jeffrey T Borenstein
SMSarine Markossian
Sarine Markossian
The National Center for Advancing Translational Sciences (NCATS) Assay Guidance Manual (AGM) Workshop on 3D Tissue Models for Antiviral Drug Development, held virtually on 7–8 June 2022, provided comprehensive coverage of critical concepts intended to help scientists establish robust, reproducible, and scalable 3D tissue models to study viruses with pandemic potential. This workshop was organized by NCATS, the National Institute of Allergy and Infectious Diseases, and the Bill and Melinda Gates Foundation. During the workshop, scientific experts from academia, industry, and government provided an overview of 3D tissue models’ utility and limitations, use of existing 3D tissue models for antiviral drug development, practical advice, best practices, and case studies about the application of available 3D tissue models to infectious disease modeling. This report includes a summary of each workshop session as well as a discussion of perspectives and challenges related to the use of 3D tissues in antiviral drug discovery.

6 January 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
ERE.A. Rosado-Olivieri
E.A. Rosado-Olivieri
BRB. Razooky
B. Razooky
HHHans-Heinrich Hoffmann
Hans-Heinrich Hoffmann
RSR. De Santis
R. De Santis
CRCharles Rice
Charles Rice
ABAli Brivanlou
Ali Brivanlou
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the global COVID-19 pandemic and the lack of therapeutics hinders pandemic control 1–2 . Although lung disease is the primary clinical outcome in COVID-19 patients 1–3 , how SARS-CoV-2 induces tissue pathology in the lung remains elusive. Here we describe a high-throughput platform to generate tens of thousands of self-organizing, nearly identical, and genetically matched human lung buds derived from human pluripotent stem cells (hPSCs) cultured on micropatterned substrates. Strikingly, in vitro -derived human lung buds resemble fetal human lung tissue and display in vivo -like proximo-distal coordination of alveolar and airway tissue differentiation whose 3D epithelial self-organization is directed by the levels of KGF. Single-cell transcriptomics unveiled the cellular identities of airway and alveolar tissue and the differentiation of WNT hi cycling alveolar stem cells, a human-specific lung cell type 4 . These synthetic human lung buds are susceptible to infection by SARS-CoV-2 and endemic coronaviruses and can be used to track cell type-dependent susceptibilities to infection, intercellular transmission and cytopathology in airway and alveolar tissue in individual lung buds. Interestingly, we detected an increased susceptibility to infection in alveolar cells and identified cycling alveolar stem cells as targets of SARS-CoV-2. We used this platform to test neutralizing antibodies isolated from convalescent plasma that efficiently blocked SARS-CoV-2 infection and intercellular transmission. Our platform offers unlimited, rapid and scalable access to disease-relevant lung tissue that recapitulate key hallmarks of human lung development and can be used to track SARS-CoV-2 infection and identify candidate therapeutics for COVID-19.

19 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JPJérémie Le Pen
Jérémie Le Pen
GPGabrielle Paniccia
Gabrielle Paniccia
VKVolker Kinast
Volker Kinast
MMMarcela Moncada-Velez
Marcela Moncada-Velez
AAAlison Ashbrook
Alison Ashbrook
CRCharles Rice
Charles Rice
Interferons (IFNs) play a crucial role in the regulation and evolution of host-virus interactions. Here, we conducted a genome-wide arrayed CRISPR knockout screen in the presence and absence of IFN to identify human genes that influence SARS-CoV-2 infection. We then performed an integrated analysis of genes interacting with SARS-CoV-2, drawing from a selection of 67 large-scale studies, including our own. We identified 28 genes of high relevance in both human genetic studies of COVID-19 patients and functional genetic screens in cell culture, with many related to the IFN pathway. Among these was the IFN-stimulated gene PLSCR1 . PLSCR1 did not require IFN induction to restrict SARS-CoV-2 and did not contribute to IFN signaling. Instead, PLSCR1 specifically restricted spike-mediated SARS-CoV-2 entry. The PLSCR1-mediated restriction was alleviated by TMPRSS2 over-expression, suggesting that PLSCR1 primarily restricts the endocytic entry route. In addition, recent SARS-CoV-2 variants have adapted to circumvent the PLSCR1 barrier via currently undetermined mechanisms. Finally, we investigate the functional effects of PLSCR1 variants present in humans and discuss an association between PLSCR1 and severe COVID-19 reported recently.